Tellus Therapeutics, Inc. — Form D
Tellus Therapeutics, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-21. The offering totals $35.0M, of which $16.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-02-21
- Form: D
- Accession: 0001766205-23-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $35.0M
- Amount sold: $16.0M
- Remaining: $19.0M
- Investors: 1
- Date of first sale: 2022-11-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-473928
Issuer
- Name: Tellus Therapeutics, Inc.
- CIK: 0001766205
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 8 DAVIS DRIVE, DURHAM, NC, 27709
- Phone: 919-491-4995
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Eric J Benner | Director | Durham, NC |
| Fred J Callori | Director | Durham, NC |
| Chris J Garabedian | Director | Durham, NC |
| Jason E Kralic | Director | Durham, NC |
| Eric J Benner | Executive Officer | Durham, NC |
| Jason E Kralic | Executive Officer | Durham, NC |
| Jason E Karlic | Director | Hillsborough, NC |
| Jason E Karlic | Executive Officer | Hillsborough, NC |
| Alex M Ruckdaeschel | Director | Hillsborough, NC |
Other filings by this issuer (2)
More